ONCOSIMIS BIOTECH
ONCOSIMIS BIOTECH
  • Home
  • Products
  • Technology
  • Pipeline
  • Awards
  • Contact Us
  • More
    • Home
    • Products
    • Technology
    • Pipeline
    • Awards
    • Contact Us
  • Home
  • Products
  • Technology
  • Pipeline
  • Awards
  • Contact Us

mAbOn-A®: High-Capacity Protein A Resin

Comparison of mAbOn-A® and competitors in human serum IgG binding capacity and SDS-PAGE analysis.

mAbOn-A® is a next-generation high-capacity protein resin developed using a recombinant E. coli-secreted Protein A ligand, covalently immobilized on highly cross-linked agarose beads. Engineered for high dynamic binding capacity, excellent alkaline stability, and reduced ligand leakage, mAbOn-A® delivers superior biotech purification solutions compared to leading global resins—at a fraction of the cost.

DRNAse® Endonuclease

Biological reagents by Oncosimis, featuring DRNAse enzyme products.

DRNase® is a secreted recombinant endonuclease enzyme derived from S. marcescens, produced through a microbial fermentation process utilizing BacSec® Technology with E. coli as the host. This recombinant endonuclease, DRNase®, is encoded by the same gene as Benzonase® from Merck-Millipore. However, while DRNase® is a monomeric enzyme, Benzonase® functions as a dimer. Both products are integral to biotech purification solutions, particularly when used in conjunction with high-capacity protein resin.

rDNAse® Endonuclease

Bottles of rDNase enzyme product from Oncosimis with company logo and tagline.

rDNase® is a secreted recombinant endonuclease clone of Bovine Pancreatic DNase I, produced by a microbial fermentation process utilizing BacSec® Technology and E.coli as the host, making it an ideal choice for biotech purification solutions that require high-capacity protein resin.

Recombinant Streptavidin

Table of recombinant streptavidin specifications and SDS-PAGE gel image showing protein bands.

Recombinant Streptavidin is a tetrameric biotin-binding protein expressed and secreted from E. coli using BacSec® platform technology. It exhibits extremely high affinity for biotin (Kd ≈ 10⁻¹⁵M), making it an ideal tool for a wide range of biotin-based detection, purification, and immobilization applications. This makes it particularly valuable in biotech purification solutions. Unlike avidin, streptavidin lacks glycosylation and has a near-neutral isoelectric point, reducing nonspecific binding. Additionally, it can be effectively utilized in conjunction with high-capacity protein resin for various applications, including those requiring recombinant endonuclease.

Oncosimis Brochure (pdf)

Download

mAbOnA® Protein A Resin (pdf)

Download

Recombinant Streptavidin_DataSheet (pdf)

Download

Request for a Sample/Quotation

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Copyright © 2025 Oncosimis® Biotech Pvt Ltd - All Rights Reserved.


Powered by

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close